Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: Data from the CATIE schizophrenia trial sample at baseline
- 1 September 2006
- journal article
- research article
- Published by Elsevier BV in Schizophrenia Research
- Vol. 86 (1-3), 15-22
- https://doi.org/10.1016/j.schres.2006.06.026
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Mental Health (01MH90001)
This publication has 54 references indexed in Scilit:
- Schizophrenia and increased risks of cardiovascular diseaseAmerican Heart Journal, 2005
- The Atypical Antipsychotic Therapy and Metabolic Issues National SurveyJournal of Clinical Psychopharmacology, 2004
- Use of Psychiatric and Medical Health Care by Veterans With Severe Mental IllnessPsychiatric Services, 2004
- Community-Based screening for cardiovascular disease and diabetes using HbA1cAmerican Journal of Preventive Medicine, 2004
- Epidemiology of DiabetesThe Journal of Clinical Pharmacology, 2004
- Undertreatment and overtreatment with statins: the Oslo Health Study 2000–2001Journal of Internal Medicine, 2004
- The Urgent Need to Improve Hypertension CareArchives of Family Medicine, 2000
- Excess mortality of schizophreniaThe British Journal of Psychiatry, 1997
- Mortality Among Patients With SchizophreniaSchizophrenia Bulletin, 1996
- Mortality and Causes of Death in First Admitted Schizophrenic PatientsThe British Journal of Psychiatry, 1993